USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $0.66, $0.31 better than the analyst estimate of $0.35. Revenue for the quarter came in at $228 million versus the consensus estimate of $203.8 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.